Showing results (71-80 of 76) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Annals of Hematology|May 17, 2023
Therapy results in pediatric Hodgkin lymphoma - does less mean better? Experience from a single children's oncology centerJoanna Stankiewicz, Andrzej Kołtan, Ewa Demidowicz, et al.British Journal of Haematology|December 4, 2019
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4Jan Walewski, Ewa Paszkiewicz-Kozik, Wojciech Michalski, et al.British Journal of Haematology|April 1, 2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphomaEwa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner, et al.Contemporary Oncology (Poznan, Poland)|February 26, 2024
Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia Berlin-Frankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemiaMagdalena Samborska, Jolanta Skalska-Sadowska, Robert Achkar, et al.Open Forum Infectious Diseases|March 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA RegistryJon Salmanton-García, Francesco Marchesi, Erica Mackenzie, et al.American Journal of Hematology|December 23, 2024
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA ReportJon Salmanton-García, Francesco Marchesi, Milan Navrátil, et al.Pageof 8